Home/Filings/4/0001867096-24-000109
4//SEC Filing

Fairley Ricki Louise 4

Accession 0001867096-24-000109

CIK 0001867096other

Filed

Jun 4, 8:00 PM ET

Accepted

Jun 5, 4:19 PM ET

Size

4.9 KB

Accession

0001867096-24-000109

Insider Transaction Report

Form 4
Period: 2024-06-05
Transactions
  • Award

    Common Stock

    2024-06-05+50,000135,000 total
Footnotes (1)
  • [F1]These shares were acquired pursuant to a restricted stock unit award under the Company's 2018 Stock Option and Incentive Plan. Each restricted stock represents a contingent right to receive one share of the Company's common stock. These shares shall vest in full upon the earlier to occur of June 5, 2025 or the date of the Company's next annual meeting of stockholders.

Issuer

Xeris Biopharma Holdings, Inc.

CIK 0001867096

Entity typeother

Related Parties

1
  • filerCIK 0001971350

Filing Metadata

Form type
4
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 4:19 PM ET
Size
4.9 KB